Literature DB >> 2102087

Localization of apolipoprotein E in normal and atherosclerotic human aorta.

V R Babaev1, A D Dergunov, A A Chenchik, E M Tararak, E V Yanushevskaya, I N Trakht, C Sorg, V N Smirnov.   

Abstract

To elucidate the role of apolipoprotein E (apo E) in atherogenesis, we have investigated the localization of apo E in normal and atherosclerotic aortas as well as in other tissues of 32 post-mortem individuals. Using double immunofluorescence it has been found that normal intima of individuals older than 20 years and some adolescents contained immunoreactive material that reacted with poly- and monoclonal antibodies to apo E. A staining pattern of apo E differed from that of apolipoprotein B, the latter being seen in normal intima of each child older than 7 years. Apo E was present extracellularly in lipid streaks and atheromatous plaques, where its staining was particularly intensive around the necrotic zone of plaques. Some macrophages in the plaques of 4 aortas exhibited apo E-positive staining, while aortic endothelial and smooth muscle cells never contained apo E. Apo E-positive staining was not found in the majority of vessel cells, it was always, however, observed in other types of cells including hepatocytes. Kupffer cells, spleen macrophages and cerebral astrocytes. Our findings indicate that only some macrophages in human aorta may be responsible for the production of apo E that can participate in reverse cholesterol transport. At the same time, apo E accumulation in the aortic wall may promote the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2102087     DOI: 10.1016/0021-9150(90)90116-z

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Effects of Ava II and Hinc II polymorphisms at the LDL receptor gene on serum lipid levels of Brazilian individuals with high risk for coronary heart disease.

Authors:  L A Salazar; M H Hirata; S D Giannini; N Forti; J Diament; J S Issa; R D Hirata
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions.

Authors:  J Luoma; T Hiltunen; T Särkioja; S K Moestrup; J Gliemann; T Kodama; T Nikkari; S Ylä-Herttuala
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma.

Authors:  R N Salomon; R Underwood; M V Doyle; A Wang; P Libby
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

4.  Renal apolipoproteins in nephrotic rats.

Authors:  H van Goor; M L van der Horst; J Atmosoerodjo; J A Joles; A van Tol; J Grond
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

5.  Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall.

Authors:  H Shimano; J Ohsuga; M Shimada; Y Namba; T Gotoda; K Harada; M Katsuki; Y Yazaki; N Yamada
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

6.  VPO1 mediates ApoE oxidation and impairs the clearance of plasma lipids.

Authors:  Youfeng Yang; Zehong Cao; Ling Tian; W Timothy Garvey; Guangjie Cheng
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.